ANAPTYSBIO INC. | Market Exclusive

Home Tags ANAPTYSBIO INC.

AnaptysBio Inc (NASDAQ:ANAB) gets downgraded to Hold by Stifel Nicolaus with...

ME Staff - June 21, 2019 0

AnaptysBio Inc (NASDAQ:ANAB) had its Buy rating reiterated by Cantor Fitzgerald...

ME Staff - February 27, 2019 0

AnaptysBio Inc (NASDAQ:ANAB) has coverage initiated with a Buy rating

ME Staff - February 22, 2019 0

AnaptysBio Inc (NASDAQ:ANAB) price target set to $140.00 by Cantor Fitzgerald

ME Staff - October 16, 2018 0

AnaptysBio Inc (NASDAQ:ANAB) price target set to $147.00 by Credit Suisse...

ME Staff - September 27, 2018 0

AnaptysBio Inc (NASDAQ:ANAB) had its Outperform rating reiterated by Wedbush with...

ME Staff - September 18, 2018 0

AnaptysBio Inc (NASDAQ:ANAB) price target set to $127.00 by Stifel Nicolaus

ME Staff - September 14, 2018 0

AnaptysBio Inc (NASDAQ:ANAB) has coverage initiated with a Buy rating and...

ME Staff - September 4, 2018 0

AnaptysBio Inc (NASDAQ:ANAB) price target set to $153.00 by JMP Securities

ME Staff - August 15, 2018 0

Insider Trading Activity AnaptysBio, Inc. (NASDAQ:ANAB) – Major Shareholder Sold 178,600...

ME Staff - August 16, 2017 0

12 Page 1 of 2

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

November 18, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 11-11-2024

November 10, 2024

Weekly Roundup on the Cannabis Sector & Psychedelic Sector 10-28-2024

October 27, 2024

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: ANAPTYSBIO INC.